Fundraising Fox
/Companies
Sign in

Sarcio

Apple Valley, US · Founded 2020 · Minnesota corporation · 1 known investors

Find your way into Sarcio

Sign up to see every warm intro you have to Sarcio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sarcio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Sarcio Inc. is a University of Minnesota Stem Cell Institute spin-out developing regenerative, disease-modifying therapeutics by isolating exosomes from iPSC-derived cartilage tissue to treat osteoarthritis and restore joint function. The company aims to delay or eliminate the need for joint-replacement surgery.

BiotechDigital HealthMedical Devices

Founders & leadership

Sarcio was founded in 2020 by Timothy D. O'Brien and Timothy D. O'Brien, DVM, PhD, DACVP.

TDTimothy D. O'Brien
Timothy D. O'BrienFounder & Chief Scientific Officer, DirectorTimothy D. O'Brien holds a Doctor of Veterinary Medicine and Doctor of Philosophy in Veterinary Pathology from the University of Minnesota-Twin Cities, and is board certified in veterinary anatomic pathology. He was a faculty member at the University of Minnesota Stem Cell Institute conducting research on organoid formation from human induced pluripotent stem cells for neurological disease modeling and cartilage repair therapeutics.
TD
Timothy D. O'Brien, DVM, PhD, DACVPFounder & Chief Scientific Officer, Director
TOTimothy O'Brien
Timothy O'BrienChief Scientific Officer & DirectorTimothy O'Brien holds a DVM and PhD in veterinary pathology from the University of Minnesota and is board certified in veterinary anatomic pathology. He is Chief Scientific Officer and Director of Sarcio, a University of Minnesota Stem Cell Institute spin-out, and previously conducted research on organoid development from human induced pluripotent stem cells for applications in disease modeling and therapeutic cartilage repair.
AV
Amanda VegoeFounder & Chief Operations Officer
BLBeth Lindborg
Beth LindborgFounder & Chief Executive Officer, DirectorBeth Lindborg is founder and CEO of Sarcio, a University of Minnesota Stem Cell Institute spin-out developing exosome-based regenerative therapeutics derived from iPSC cartilage tissue to treat osteoarthritis.
MT
Marc TompkinsChief Medical Officer
MW
Michael WilliamsChief Business Officer

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 2 rounds · 2021

▶$785.3KraisedAug 2023 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Beth LindborgExecutive Officer, Director
  • Michael WilliamsDirector
  • Amanda VegoeExecutive Officer
  • Marc TompkinsExecutive Officer
  • Timothy O'BrienExecutive Officer, Director
Offering amount
$850K
Amount sold
$785.3K
Proceeds to insiders
$120K
First sale
Mar 2021
Incorporated
Corporation, Minnesota, 2020
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$607.5KraisedJul 2023 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy O'BrienExecutive Officer, Director
  • Amanda VegoeExecutive Officer
  • Beth LindborgExecutive Officer, Director
  • Marc TompkinsExecutive Officer
  • Michael WilliamsDirector
Offering amount
$750K
Amount sold
$607.5K
First sale
Dec 2021
Incorporated
Corporation, Minnesota, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Sarcio do?
Sarcio Inc. is a University of Minnesota Stem Cell Institute spin-out developing regenerative, disease-modifying therapeutics by isolating exosomes from iPSC-derived cartilage tissue to treat osteoarthritis and restore joint function. The company aims to delay or eliminate the need for joint-replacement surgery.
Who founded Sarcio?
Sarcio was founded by Timothy D. O'Brien, Timothy D. O'Brien, DVM, PhD, DACVP in 2020.
Who are Sarcio's investors?
Sarcio's investors include GROOVE CAPITAL.
How much funding has Sarcio raised?
Sarcio has disclosed $1.4M raised across 2 rounds.
Where is Sarcio headquartered?
Sarcio is headquartered in Apple Valley, US.